We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSA icon
276
Public Storage
PSA
$60.3B
$391M 0.08%
2,119,909
-5,003
-0.2% -$960K
RAX
277
DELISTED
Rackspace Hosting Inc
RAX
$391M 0.08%
10,503,449
-874,668
-8% -$40.2M
DVA icon
278
DaVita
DVA
$11.4B
$390M 0.08%
4,906,245
-1,109,575
-18% -$91.1M
CAH icon
279
Cardinal Health
CAH
$55B
$388M 0.08%
4,637,066
+74,777
+2% +$6.6M
DD
280
DELISTED
Du Pont De Nemours E I
DD
$387M 0.08%
6,377,502
-12,235,374
-66% -$824M
INTC icon
281
Intel
INTC
$508B
$387M 0.08%
12,709,210
-312,163
-2% -$10.1M
VEEV icon
282
Veeva Systems
VEEV
$38.1B
$384M 0.08%
13,685,590
+2,417,600
+21% +$65.6M
VTRS icon
283
Viatris
VTRS
$18.7B
$383M 0.08%
5,643,195
-1,360,012
-19% -$96.1M
GRUB
284
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$383M 0.08%
5,619,904
+207,470
+4% +$16.8M
MAN icon
285
ManpowerGroup
MAN
$2.55B
$380M 0.08%
4,248,409
-929,131
-18% -$80.1M
WST icon
286
West Pharmaceutical
WST
$24.6B
$378M 0.08%
6,510,496
+1,377,986
+27% +$76.9M
INGR icon
287
Ingredion
INGR
$6.53B
$376M 0.08%
4,713,597
+304,059
+7% +$24.4M
CYT
288
DELISTED
CYTEC INDS INC
CYT
$375M 0.08%
6,194,593
+1,465,084
+31% +$85.2M
WWAV
289
DELISTED
The WhiteWave Foods Company
WWAV
$374M 0.08%
7,643,431
-2,469,320
-24% -$116M
LPLA icon
290
LPL Financial
LPLA
$29.3B
$373M 0.08%
8,025,742
-25,020
-0.3% -$1.08M
LBTYA icon
291
Liberty Global Class A
LBTYA
$3.55B
$373M 0.08%
8,361,562
-235,589
-3% -$10.5M
PSMT icon
292
Pricesmart
PSMT
$5.4B
$372M 0.08%
4,072,884
+251,194
+7% +$21M
WMT icon
293
Walmart Inc
WMT
$914B
$370M 0.08%
15,657,549
-4,410,057
-22% -$112M
DFS
294
DELISTED
Discover Financial Services
DFS
$362M 0.07%
6,274,802
-611,687
-9% -$35.9M
MKC icon
295
McCormick & Company Non-Voting
MKC
$14.2B
$359M 0.07%
8,858,386
-8,746
-0.1% -$340K
STX icon
296
Seagate
STX
$199B
$356M 0.07%
7,498,980
+1,542,860
+26% +$85.2M
RYN icon
297
Rayonier
RYN
$6.4B
$356M 0.07%
15,353,598
+1,239,507
+9% +$29.1M
ORCL icon
298
Oracle
ORCL
$428B
$355M 0.07%
8,812,723
-107,527
-1% -$4.66M
SPLS
299
DELISTED
Staples Inc
SPLS
$355M 0.07%
23,162,648
+145,580
+0.6% +$2.37M
K
300
DELISTED
Kellanova
K
$355M 0.07%
6,022,664
-1,430,037
-19% -$85.5M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.